{"transactions":[{"id":791920,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-05T20:41:48.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":152783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the \"Plan\"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan)."}],"balance_after":152783,"derivative":{"exercise_price":0.841,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":152783},"source":{"system":"sec-edgar","filing":"0001213900-26-052260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390026052260/ownership.xml","form_type":"4"}},{"id":985226,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T13:54:08.000Z","date":"2025-11-28","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":0.75,"value":24999.75,"ownership":{"direct":true},"balance_after":35833,"source":{"system":"sec-edgar","filing":"0001213900-25-116299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390025116299/ownership.xml","form_type":"4"}},{"id":1013284,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-27T21:25:59.000Z","date":"2025-10-24","kind":"grant","planned":false,"acquired":true,"shares":42913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan, as amended (the \"Plan\"). The shares of the Issuer's common stock, par value $0.0001 per share, underlying the Option will vest in full upon the one-year anniversary of the date of grant; provided, that the Reporting Person remains a director of the Issuer through such vesting date; provided further, that the shares underlying the Option will fully vest upon a Change in Control (as defined in the Plan)."}],"balance_after":42913,"derivative":{"exercise_price":0.715,"expiration_date":"2035-10-23","underlying":"Common Stock","underlying_shares":42913},"source":{"system":"sec-edgar","filing":"0001213900-25-102674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390025102674/ownership.xml","form_type":"4"}},{"id":1546902,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-06T01:45:30.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The sole purpose of this Form 4/A is to correct the exercise price, which was previously reported erroneously as $8.34 per share. The correct exercise price, based upon the closing price of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), on March 1, 2024, was $8.13 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of Common Stock underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":8.13,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-030958","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390024030958/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1607549,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-02T02:45:45.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option (the \"Option\") award was made in accordance with the terms of the Issuer's 2023 Stock Incentive Plan. The shares of the Issuer's common stock, par value $0.0001 per share (\"Common Stock\"), underlying the Option will vest at the rate of 33% upon the one-year anniversary of the date of grant and 33% on each successive one-year anniversary thereafter; provided, that the Reporting Person remains a director of the Issuer through such vesting date."}],"balance_after":7500,"derivative":{"exercise_price":8.34,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-24-019217","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390024019217/ownership.xml","form_type":"4"}},{"id":2112577,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (to acquire Common Stock)","published_at":"2022-11-17T21:34:41.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted 100,000 stock options which have a ten-year term. The option is vested and exercisable with regard to 50,000 shares of Common Stock. The remaining 50% vest, subject to Mr. Dumesnil's remaining employed and in good standing, on August 2, 2023."}],"balance_after":100000,"derivative":{"exercise_price":6,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-22-073502","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390022073502/ownership.xml","form_type":"4"}},{"id":2112576,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T21:34:41.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":40000,"price":1.06,"value":42400.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001213900-22-073502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390022073502/ownership.xml","form_type":"4"}},{"id":2112575,"issuer":{"id":7685,"kind":"organization","name":"Pasithea Therapeutics Corp."},"owners":[{"id":49674,"kind":"person","name":"Dumesnil Simon","position":1,"cik":"0001875691","reported_name":"Dumesnil Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-17T21:34:41.000Z","date":"2022-11-15","kind":"grant","acquired":true,"shares":10000,"price":1.07,"value":10700.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001213900-22-073502","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875691/000121390022073502/ownership.xml","form_type":"4"}}]}